跳至主要内容
临床试验/JPRN-UMIN000045409
JPRN-UMIN000045409招募中未知

A study on the prevention of exacerbation of oral mucositis by early initiation of Episil oral liquid in hematopoietic stem cell transplant recipients and head and neck cancer patients - A study on prevention of oral mucositis exacerbation by early initiation of Episil oral liquid

Fujita Health University0 个研究点目标入组 90 人开始时间: 2021年9月7日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who need assistance in using Episil. 2) Patients with lesions including the central nervous system (CNS), or having confirmed/suspected of metastasis/invasion in the CNS 3) Patients using opioids for pain management prior to the start of Episil administration. 4) Patients with serious infections or complication. 5) Patients with known allergy to any of the ingredients in Episil. 6) Patients judged to be inappropriate by the investigator.

研究者

相似试验